SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Public-private partnership: from there to here
3 references·3 citing·21 second hop
Public-private partnership: from there to here (2005)Public-private partnership: from there to…Virtual drug discovery and development for neglected diseases through public–private partnerships (2003)Virtual drug discovery and de…Drug development for neglected diseases: a deficient market and a public-health policy failure (2002)Drug development for neglecte…Access to Essential Drugs in Poor Countries (1999)Access to Essential Drugs in …Integrating Infrastructure and Clinical Management in PPPs for Health Care (2013)Integrating Infrastructure an…The role of Product Development Partnerships in research and development for neglected diseases (2010)The role of Product Developme…Docking for Neglected Diseases as Community Efforts (2008)Docking for Neglected Disease…Global public-private partnerships: Part II--What are the health issues for global governance? (2000)Neglected Disease Research and Development: How Much Are We Really Spending? (2009)Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature (2017)Global public-private partnerships: Part I--A new development in health? (2000)Portugal:: Health System review, 2017 (2017)Sustainable Public Procurement Policies on Promoting Scientific and Technological Innovation in China: Comparisons with the U.S., the UK, Japan, Germany, France, and South Korea (2018)Systematic analysis of PPP research in construction journals: from 2009 to 2019 (2020)Using a Choquet integral-based approach for incorporating decision-maker’s preference judgments in a Data Envelopment Analysis model (2020)Human Development Report 2001: Making new technologies work for human development (2001)Intellectual property rights, the WTO and developing countries: the TRIPS agreement and policy options (2001)25 years of the WHO essential medicines lists: progress and challenges (2003)HUMAN RIGHTS AND GLOBAL HEALTH: A RESEARCH PROGRAM (2005)The price of innovation: new estimates of drug development costs (2003)Cyberinfrastructure: Empowering a "Third Way" in Biomedical Research (2005)Cost of innovation in the pharmaceutical industry (1991)Priority medicines for Europe and the world (2004)Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression (2009)Exploring different approaches to improve the success of drug discovery and development projects: a review (2020)Pharmaceuticals and the Developing World (2002)Access to medicines from a health system perspective (2012)The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment (2013)
this work references cited by second hop

References

  • 2002Drug development for neglected diseases: a deficient market and a public-health policy failure895 cited
  • 1999Access to Essential Drugs in Poor Countries396 cited
  • 2003Virtual drug discovery and development for neglected diseases through public–private partnerships259 cited

Cited by

  • 2010The role of Product Development Partnerships in research and development for neglected diseases65 cited
  • 2013Integrating Infrastructure and Clinical Management in PPPs for Health Care40 cited
  • 2008Docking for Neglected Diseases as Community Efforts11 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work